✦ LIBER ✦

Chronic hepatitis C: Comparison of two methods of genotyping and quantification of HCV RNA in the response to interferon therapy (IFN)

Book ID: 118566687
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 136 KB
Volume: 21
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80883-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of interferon effect in chron

Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA

✍ G. Yamada; M. Takahashi; R. Miyamoto; T. Tsuji; H. Yoshizawa; H. Okamoto 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 88 KB

Quantification and genotyping of serum H

Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment

✍ G. Gerken; P. Knolle; S. Jakobs; K.-H. Meyer zum Büschenfelde 📂 Article 📅 1997 🏛 Springer Vienna 🌐 English ⚖ 194 KB

Quantitative HCV RNA and effect of inter

Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C

✍ G. Yamada; M. Takahashi; T. Tsuji; H. Yoshizawa; H. Okamoto 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 184 KB

Genotype, serum level of HCV-RNA and res

Genotype, serum level of HCV-RNA and response to interferon-α treatment in patients with chronic hepatitis C

✍ C. Clarysse; C. Van den Eynde; F. Nevens; C. Portier; N. Aelbrecht; J. Fevery; S 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 466 KB

P-290 Serum hepatitis C virus(HCV) RNA l

P-290 Serum hepatitis C virus(HCV) RNA levels and efficacy of interferon(IFN) therapy for chronic hepatitis C in habitual drinkers

✍ K Ohnishi; S Matsuo; K Marutani; M Itabashi; N Ohyama; K Suzuki; S Ito; K Fujiwa 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Rapid viral response and treatment outco

Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods

✍ Tony Carlsson; Anne Quist; Ola Weiland 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Fifty consecutive patients with genotype 2 or 3 chronic hepatitis C were treated with peg‐IFN alfa‐2a 135 µg weekly and ribavirin (11 mg/kg body weight) daily during 24 weeks. Rapid viral response treatment week 4, end‐of‐treatment response, and sustained viral response were analyzed by